CLINICAL IMPACT SUMMARY

Transcutaneous Monitoring in the PICU: Clinical Impact & Utility

CLINICAL IMPACT SUMMARY

Transcutaneous Monitoring in the PICU: Clinical Impact & Utility

CLINICAL IMPACT SUMMARY

Transcutaneous Monitoring in the PICU: Clinical Impact & Utility

How can transcutaneous monitoring make a difference for your patients?

The Sentec Transcutaneous Monitoring System provides continuous visibility into patient ventilatory status, allowing clinicians to provide more proactive, timely interventions.  By overcoming the limitations of end-tidal CO2 and providing better compatibility with all modes of ventilation, transcutaneous CO2 monitoring helps clinicians assess patient condition and the efficacy of treatment and ventilatory support strategies.

This paper explores transcutaneous monitoring in the PICU therapy within the literature, covering:

  • The parallel trend lines of increasing noninvasive ventilation usage and growing admission rates for patients with conditions like asthma, PARDS, and bronchiolitis

  • Emerging data that suggests choosing a less invasive strategy, even among noninvasive ventilation methods, can have a significant, positive effect on patient outcomes

  • How monitoring patients solely with pulse oximetry provides an incomplete picture of patient respiratory status
  • The limitations of arterial blood gases (ABGs), including that they provide only point-in-time measurements that can result in misrepresentation of the patient course
  • How etCO2 is ill-suited for many patients in the PICU population, due to its incompatibility and inconsistency with noninvasive and specialty ventilation strategies
  • The demonstrated accuracy and safety of transcutaneous monitoring of CO2 for use in the PICU population
  • The indication of transcutaneous monitoring in the AARC and the Pediatric Acute Lung Injury Consensus Conference Group
transcutaneous monitoring in the PICU: clinical utility and impact

How can transcutaneous monitoring make a difference for your patients?

The Sentec Transcutaneous Monitoring System provides continuous visibility into patient ventilatory status, allowing clinicians to provide more proactive, timely interventions.  By overcoming the limitations of end-tidal CO2 and providing better compatibility with all modes of ventilation, transcutaneous CO2 monitoring helps clinicians assess patient condition and the efficacy of treatment and ventilatory support strategies.

This paper explores transcutaneous monitoring in the PICU therapy within the literature, covering:

  • Emerging data on noninvasive ventilation in the PICU suggests that choosing a less invasive strategy, even among noninvasive ventilation methods, can have a significant, positive effect on patient outcomes.

  • Monitoring patients solely with pulse oximetry provides an incomplete picture of patient respiratory status

  • Arterial blood gases (ABGs) are invasive, painful procedures that, although a gold standard, provide only point-in-time measurements that can result in misrepresentation of the patient course.

  • End-tidal CO2 (etCO2) is ill-suited for many patients in the PICU population, due to its incompatibility with noninvasive and specialty ventilation strategies and inconsistencies as compared to ABGs, particularly in patients with compromised lungs and conditions like V/Q mismatch.

  • Transcutaneous monitoring of CO2 (tcPCO2) is accurate and safe for use in the PICU population.

Meet the tCOM+

Developed with care, designed for confidence.

The tCOM+ offers continuous monitoring of tcPCO2, SpO2, and PR with a sleek new look and feel. This latest model includes significant software advances that improve workflow for providers, while continuing to support reduced blood draws and proactive ventilator management across care areas.

tCOM-device-angled

Stay up-to-date with Sentec